Hisamitsu Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of HTSUF for the last quarter is 259.17 M USD, and it's 7.18% higher compared to the previous quarter. The net income of Q4 23 is 12.40 M USD.